The invention relates to solid state forms of androst-5-ene-3.beta.,7.beta.,16.alpha.,17.beta.-triol, formulations containing or prepared from such solid state forms and use of such materials for modulating acute and chronic non-productive inflammation. The formulations can be used to prevent, treat or slow the progression of conditions related to autoimmunity such as arthritis, multiple sclerosis, ulcerative colitis or Type 1 diabetes. The formulations can also be used to prevent, treat or slow the progression of conditions related to metabolic disorders such as Type 2 diabetes.

 
Web www.patentalert.com

< COCRYSTAL OF C-GLYCOSIDE DERIVATIVE AND L-PROLINE

> Anxiolytic Marcgraviaceae Compositions Containing Betulinic Acid, Betulinic Acid Derivatives, and Methods

> PYRROLO-PYRIDINE KINASE MODULATIORS

~ 00524